Skip to content
Environment, Medical Health Aged Care

Doctors issue warning about Kalgoorlie heat and blackout

Doctors for the Environment Australia 2 mins read

January 19, 2024

 

Doctors are worried about the health impacts of the heatwave and prolonged power outage in Kalgoorlie, WA.

 

Doctors for the Environment Australia’s spokesperson and Perth GP Dr George Crisp says, “Heat is dangerous to health and remains our biggest killer, and it’s critical that people have access to cooling.

 

“As well as the risks of heat exhaustion and heat stroke in these extreme conditions, we know that heat exposure increases the risks of many serious illnesses such as heart and respiratory diseases, mental health presentations and premature births.

 

“Certain people have a higher risk of illness during heatwaves. These include older adults, and individuals with underlying health conditions and in the case of Kalgoorlie, those reliant on electricity-dependent medical equipment.

 

“Like food, medicines are perishable products and will degrade with exposure to higher temperatures. Some medicines need to be refrigerated between +2°C and +8°C or their effectiveness can deteriorate.  

 

“If the power has been off for a while and people are concerned about a particular medicine, they need to contact their pharmacist or doctor.”

 

Tips to stay safe in the heat:

  • drink water to stay hydrated
  • avoid alcohol
  • use cold washcloths, especially on the back of your neck
  • get in the bath, or put your feet in a bowl of water
  • wear wet clothes
  • do not leave anyone in parked cars
  • provide enough shade and water for pets
  • air hot buildings whenever it is cooler outside — usually this is at night
  • Check on vulnerable family members and neighbours

Says Dr Crisp, “We are seeing increased extreme weather events, the latest storm and power outage s an example of exactly what has been foreshadowed as a consequence of climate change. Ditching gas and coal and switching to renewables will reduce the risks to our health.”

 

Handy fact sheet on heat and health

 

Media contact

DEA’s Media and Communications Lead, Carmela Ferraro, 04107 03074

 

About DEA

Doctors for the Environment Australia (DEA) is an organisation of medical professionals that protect human health through care of the environment.  Our members are GPs, surgeons, physicians, anaesthetists, psychiatrists, paediatricians, public health specialists, academics, medical students and researchers.

 

—-ENDS—

More from this category

  • Environment, General News
  • 08/12/2025
  • 12:38
Australian Conservation Foundation

ACF spokespeople available for interview on bushfires and climate/nature risk

As another dangerous summer begins – with bushfires having already destroyed dozens of houses and one firefighter having been killed – Australian Conservation Foundation spokespeople are available for media analysis on extreme weather. ACF spokespeople can: Discuss the impact of bushfires on nature, threatened species and communities Join the dots between extreme weather, the unstable climate and the expansion of the gas industry ACF’s campaigns director Dr Paul Sinclair said: “Australians are at the forefront of the climate crisis and experts warn the unstable climate is making extreme weather events harder to predict. “The direct costs of climate change are…

  • Medical Health Aged Care
  • 08/12/2025
  • 10:11
BeOne Medicines Ltd.

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid…

  • Contains:
  • Medical Health Aged Care
  • 08/12/2025
  • 09:40
Miltenyi Biomedicine

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease featuresA 12-day manufacturing time resulted in a vein-to-vein time of 14-16 days, reducing the likelihood for bridging therapy.BERGISCH GLADBACH, Germany, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Miltenyi Biomedicine today announced results from the pivotal DALY 2-EU trial evaluating the efficacy and safety of zamtocabtagene autoleucel (zamto-cel) compared with standard chemoimmunotherapy (R-GemOx or Pola-BR) in patients with…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.